In recent times, enormous progress has been made in improving the diagnosis and
therapeutic strategies for breast carcinoma, yet it remains the most prevalent cancer and …

This review summarizes advances in our understanding of the genomic and epigenomic
abnormalities in breast cancers that are being revealed by the increasingly powerful suite of …

Breast cancer is a heterogeneous disease. DNA microarray technology is being applied to
breast cancer to identify new prognostic biomarkers, to predict response to therapy, and to …

In the recent years the rapid scientific innovation in the evaluation of the individual's genome
have allowed the identification of variants associated with the onset, treatment and …

Breast cancer is the most frequent female malignancy worldwide. Current strategies in
breast cancer therapy, including classical chemotherapy, hormone therapy, and targeted …

Breast cancer, rather than constituting a monolithic entity, comprises heterogeneous tumors
with different clinical characteristics, disease courses, and responses to specific treatments …

Although the introduction of novel therapies and drug combinations has improved the
prognosis of metastatic breast cancer, this disease remains incurable. It is therefore …

With the exception of non-melanoma skin cancer, breast cancer is the most frequently
diagnosed malignant disease among women, with the majority of mortality being attributable …

Breast cancer, like other cancers, is a genetic disease. The disease is caused by acquired
molecular alterations during the lifetime of an individual and by inherited mutant genes. Risk …

Personalized cancer therapy is likely to be one of the next big advances in our search for a
cure for cancer. To be able to treat people in an individualized manner, researchers need to …